Related by context. Frequent words. (Click for all words.) 67 pharmacokinetic 66 pharmacodynamics 65 PK PD 65 Pharmacokinetic 64 pharmacodynamic 64 pharmacokinetic studies 64 pharmacodynamic effects 63 secondary efficacy endpoints 63 pharmacokinetic profiles 63 Phase 1b trial 62 Phase Ia 61 phase IIb 61 dose escalation trial 61 single ascending dose 61 serologic 61 genotoxicity 60 phase IIa 60 safety tolerability pharmacokinetics 60 ISIS # 60 pharmacokinetics 60 NSABP 60 phase 2a 60 CR# vcMMAE 60 tolerability 60 Imprime PGG 60 Sym# 60 Azedra 60 DAVANAT 59 noninferiority 59 preclinical toxicology 59 Neuradiab 59 pertuzumab 59 rHuPH# 59 SABCS 59 Phase 1b clinical 59 radiolabeled 59 multiple ascending dose 59 Phase 1a 59 randomized Phase III 59 placebo controlled clinical 59 tanespimycin 59 MIRCERA 59 ataluren 59 Phase Ib 59 active comparator 59 Phase 2a clinical 59 double blinded placebo 59 pafuramidine 58 Phase 1b 58 nab paclitaxel 58 Phase IIa 58 xenograft models 58 Carfilzomib 58 Cloretazine R VNP#M 58 SWOG 58 imetelstat 58 Phase IIa clinical 58 Amrubicin 58 immunogenicity 58 glufosfamide 58 Phase 2a trial 58 administered subcutaneously 58 peripheral blood mononuclear 58 pramlintide 58 prospective randomized controlled 57 IDX# 57 Phase IIa trial 57 RGB # 57 K RAS 57 HGS ETR1 57 immunohistochemical 57 PA# [002] 57 pharmacokinetic profile 57 thymalfasin 57 efficacy 57 teduglutide 57 KNS # 57 tolerability profile 57 dose escalation 57 serum concentrations 57 CYT# 57 tolerated dose MTD 57 Secondary endpoints include 57 PRECISE 57 talabostat 57 RRMS patients 56 GRN#L 56 vicriviroc 56 vitro experiments 56 registrational trial 56 SILENOR TM 56 palifosfamide 56 registrational 56 decitabine 56 PRECiSE 56 prospective observational 56 PXD# 56 biodistribution 56 BAY #-# 56 unblinding 56 romidepsin